AptifoldContact
AN INTERACTIVE EXPLAINER APTIFOLD V1 · SCENES 1.8

MODULAR MEDICINE MANUFACTURING

The factory
in the box.

A hospital needs medicine. Fill a fictional batch and see why the containers still need review before they can ship.

REAL CASE · U.S., 2011

Production interruptions at three manufacturers disrupted supplies of norepinephrine, a medicine used in critical care.

Why this case? Sources & limits

Vail et al., JAMA (2017) documents the historical shortage. It does not identify filling as the specific bottleneck.

In a separate 7 March 2024 announcement, CHS named norepinephrine among the medicines it planned to buy from Cost Plus’s Dallas fill-finish operation. That is not evidence for a portable pod or its performance.

Our walkthrough starts at filling: it assumes the formulation comes from upstream, with suitable containers and a qualified process and site. It does not model ingredient manufacture. Neither source establishes that this hypothetical backup would have prevented the 2011 shortage.

A “pod” is a small production unit. Here it receives prepared liquid and fills final containers. Follow fictional Product A through filling and review, then compare extra stock with local production during a delivery gap. Quantities, shelf life and timing are invented, not norepinephrine data or a replay of 2011. Run production, review and stock together across 30 days ↗

An independent explainer, not an official Cost Plus Drugs site.
The models are illustrations, not clinical or production guidance.

An illustrated manufacturing pod with its cover lifted to show four work areas and a small amber robot.

FIELD NOTES

Field notes

Read two worked supply cases →

1 / 1